Search

Your search keyword '"Rubino, M"' showing total 484 results

Search Constraints

Start Over You searched for: Author "Rubino, M" Remove constraint Author: "Rubino, M" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
484 results on '"Rubino, M"'

Search Results

1. Detectability of large-scale counter-rotating stellar disks in galaxies with integral-field spectroscopy

2. Peptide receptor radionuclide therapy with 177Lu- or 90Y-SSTR peptides in malignant pheochromocytomas (PCCs) and paragangliomas (PGLs): results from a single institutional retrospective analysis

3. Nuclear Physics Mid Term Plan at LNGS

4. Effect of Migalastat on cArdiac Involvement in FabRry Disease: MAIORA study

5. Erratum: Gas transport in firn: Multiple-tracer characterisation and model intercomparison for NEEM, Northern Greenland (Atmospheric Chemistry and Physics (2012) 12 (4259-4277))

6. Corrigendum to ``Gas transport in firn: multiple-tracer characterisation and model intercomparison for NEEM, Northern Greenland'' published in Atmos. Chem. Phys., 12, 4259–-4277, 2012

7. The SGLT2I Dapagliflozin reverses metabolic stress driving myocardial inflammation in a mouse model of heart failure with preserved ejection fraction: insights from single-cell RNA sequencing

9. Gastroenteropancreatic grade 3 neuroendocrine tumors: a single entity or a heterogeneous group? A retrospective analysis

10. Metronomic chemotherapy in patients with advanced neuroendocrine tumors: A single-center retrospective analysis

11. C63 PREVALENCE AND CLINICAL SIGNIFICANCE OF RIGHT VENTRICULAR PULMONARY ARTERIAL UNCOUPLING IN CARDIAC AMYLOIDOSIS

13. COVID-19 in patients with neuroendocrine neoplasms: two-year results of the INTENSIVE study

14. Multimodal treatment for resectable neuroendocrine carcinoma of the cervix

15. Effect of Migalastat on cArdiac Involvement in FabRry Disease: MAIORA study

17. Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: data from the Campania Rare Disease Registry

18. Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry

19. HCM-AF South Italy score for prediction of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy: data from a derivation and validation italian cohorts

22. Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry

23. Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry

24. Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry

25. Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study

26. A retrospective analysis of the correlation between functional imaging and clinical outcomes in grade 3 neuroendocrine tumors (Nets g3)

27. Should temozolomide be used on the basis of O6-methylguanine DNA methyltransferase status in patients with advanced neuroendocrine tumors? A systematic review and meta-analysis

29. The GALA project: Practical recommendations for the use of migalastat in clinical practice on the basis of a structured survey among Italian experts

30. COVID-19 outbreak in Lombardy: Impact on reducing solid cancer diagnoses in 2020

31. Corrigendum to ‘Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study’ [European Journal of Cancer 154 (2021) 246-252] (European Journal of Cancer (2021) 154(246-252) (S0959804921004044), (10.1016/j.ejca.2021.06.029))

32. Antibiotic use and associated factors in a large sample of hospitalised older people

33. Diagnostic and prognostic implications of myocardial work in cardiac amyloidosis and in genetic and non-genetic cardiomyopathies with hypertrophic phenotype

34. Pathophysiological, haemodynamic and prognostic implications of left atrial dysfunction in cardiac amyloidosis and other cardiomyopathies with hypertrophic phenotype

35. Diagnostic and prognostic implications of right ventricular-arterial coupling in cardiac amyloidosis and in genetic and non-genetic cardiomyopathies with hypertrophic phenotype

36. Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register

37. Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients

38. Mortality rate and risk factors for gastrointestinal bleeding in elderly patients

39. Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids

40. Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register

41. The GALA project: Practical recommendations for the use of migalastat in clinical practice on the basis of a structured survey among Italian experts

42. Open issues on G3 neuroendocrine neoplasms: back to the future

43. Myocardial performance is impaired in cardiac amyloidosis: role of myocardial work-derived parameter in differential diagnosis with phenocopies and prognostic implications

44. Natural history of left ventricular hypertrophy in infants of diabetic mothers

46. Left atrial function is impaired in cardiac amyloidosis and other cardiomyopathies with hypertrophic phenotype: haemodynamic correlations, pathophysiological consequences and prognostic implications

47. The role of right ventricular-arterial coupling in cardiac amyloidosis: a comparison between subtypes and with other genetic and non-genetic hypertrophic cardiomyopathies and prognostic consequences

50. Emerging Therapies in Pheochromocytoma and Paraganglioma: Immune Checkpoint Inhibitors in the Starting Blocks

Catalog

Books, media, physical & digital resources